ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glaucoma Aqueous Shunt Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-17L18002
Home | Market Reports | Health| Vision Care
Global Glaucoma Aqueous Shunt Device Market Research Report 2024
BUY CHAPTERS

Global Glaucoma Aqueous Shunt Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17L18002
Report
October 2025
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Glaukos Corp
Ocular Therapeutix
PolyActiva
Nova Eye Medical
Alcon
iSTAR Medical
Henan Universe
Health Guard Biomed

Glaucoma Aqueous Shunt Device Market Size

The global Glaucoma Aqueous Shunt Device market is projected to grow from US$ 1588 million in 2024 to US$ 3589 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Glaucoma Aqueous Shunt Device Market

Glaucoma Aqueous Shunt Device Market

A glaucoma aqueous hunt device is an important surgical device for the treatment of glaucoma. It uses the drainage principle to drain excess aqueous humor from the eye to the outside of the eye, thereby reducing intraocular pressure and protecting the optic nerve.
Major players in the global glaucoma aqueous hunt device market include AbbVie, Glaukos Corp, Alcon, Santen Pharmaceutical, Johnson and Johnson, New World Medical, iSTAR Medical, and Nova Eye Medicl. In terms of glaucoma aqueous hunt device revenue in 2023, the top five manufacturers accounted for 80% of the market share.
Market Development Trends
Technological Innovation: With the continuous advancement of science and technology, glaucoma aqueous hunt device will continue to introduce new technologies and new materials to improve product performance and safety. For example, the integration of intelligent technology will make glaucoma shunts more accurate and efficient.
Personalized treatment: With the improvement of medical level and the diversification of patient needs, personalized treatment will become an important development direction of the glaucoma aqueous hunt device market. Enterprises need to provide customized products and services according to the specific conditions of patients to meet their personalized needs.
Internationalization strategy: With the development of global economic integration, the demand for glaucoma aqueous hunt device in the international market is also increasing. Enterprises will strengthen international cooperation and expand overseas markets to achieve market expansion and global business layout.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Glaucoma Aqueous Shunt Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Glaucoma Aqueous Shunt Device Market Report

Report Metric Details
Report Name Glaucoma Aqueous Shunt Device Market
Accounted market size in 2024 US$ 1588 million
Forecasted market size in 2031 US$ 3589 million
CAGR 12.5%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Trabecular Meshwork-Schlemm Canal Drainage
  • Subconjunctival Drainage
  • Others
Segment by Application
  • Hospital
  • Ophthalmology Clinics
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Glaucoma Aqueous Shunt Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Glaucoma Aqueous Shunt Device Market growing?

Ans: The Glaucoma Aqueous Shunt Device Market witnessing a CAGR of 12.5% during the forecast period 2025-2031.

What is the Glaucoma Aqueous Shunt Device Market size in 2031?

Ans: The Glaucoma Aqueous Shunt Device Market size in 2031 will be US$ 3589 million.

What is the market share of major companies in Glaucoma Aqueous Shunt Device Market?

Ans: In terms of glaucoma aqueous hunt device revenue in 2023, the top five manufacturers accounted for 80% of the market share.

Who are the main players in the Glaucoma Aqueous Shunt Device Market report?

Ans: The main players in the Glaucoma Aqueous Shunt Device Market are AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed

What are the Application segmentation covered in the Glaucoma Aqueous Shunt Device Market report?

Ans: The Applications covered in the Glaucoma Aqueous Shunt Device Market report are Hospital, Ophthalmology Clinics, Others

What are the Type segmentation covered in the Glaucoma Aqueous Shunt Device Market report?

Ans: The Types covered in the Glaucoma Aqueous Shunt Device Market report are Trabecular Meshwork-Schlemm Canal Drainage, Subconjunctival Drainage, Others

1 Study Coverage
1.1 Introduction to Glaucoma Aqueous Shunt Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glaucoma Aqueous Shunt Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Trabecular Meshwork-Schlemm Canal Drainage
1.2.3 Subconjunctival Drainage
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Glaucoma Aqueous Shunt Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glaucoma Aqueous Shunt Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Glaucoma Aqueous Shunt Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Glaucoma Aqueous Shunt Device Sales Estimates and Forecasts 2020-2031
2.4 Global Glaucoma Aqueous Shunt Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Glaucoma Aqueous Shunt Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Glaucoma Aqueous Shunt Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Trabecular Meshwork-Schlemm Canal Drainage Market Size by Manufacturers
3.5.2 Subconjunctival Drainage Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Glaucoma Aqueous Shunt Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Glaucoma Aqueous Shunt Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Glaucoma Aqueous Shunt Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Glaucoma Aqueous Shunt Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glaucoma Aqueous Shunt Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Glaucoma Aqueous Shunt Device Sales and Revenue by Type (2020-2031)
6.4 North America Glaucoma Aqueous Shunt Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Glaucoma Aqueous Shunt Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Glaucoma Aqueous Shunt Device Sales and Revenue by Type (2020-2031)
7.4 Europe Glaucoma Aqueous Shunt Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Glaucoma Aqueous Shunt Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Glaucoma Aqueous Shunt Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Glaucoma Aqueous Shunt Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Glaucoma Aqueous Shunt Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Glaucoma Aqueous Shunt Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Glaucoma Aqueous Shunt Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Glaucoma Aqueous Shunt Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Glaucoma Aqueous Shunt Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Glaucoma Aqueous Shunt Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Glaucoma Aqueous Shunt Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.1.4 AbbVie Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 AbbVie Glaucoma Aqueous Shunt Device Sales by Product in 2024
11.1.6 AbbVie Glaucoma Aqueous Shunt Device Sales by Application in 2024
11.1.7 AbbVie Glaucoma Aqueous Shunt Device Sales by Geographic Area in 2024
11.1.8 AbbVie Glaucoma Aqueous Shunt Device SWOT Analysis
11.1.9 AbbVie Recent Developments
11.2 Santen Pharmaceutical
11.2.1 Santen Pharmaceutical Corporation Information
11.2.2 Santen Pharmaceutical Business Overview
11.2.3 Santen Pharmaceutical Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.2.4 Santen Pharmaceutical Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Santen Pharmaceutical Glaucoma Aqueous Shunt Device Sales by Product in 2024
11.2.6 Santen Pharmaceutical Glaucoma Aqueous Shunt Device Sales by Application in 2024
11.2.7 Santen Pharmaceutical Glaucoma Aqueous Shunt Device Sales by Geographic Area in 2024
11.2.8 Santen Pharmaceutical Glaucoma Aqueous Shunt Device SWOT Analysis
11.2.9 Santen Pharmaceutical Recent Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Corporation Information
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.3.4 Johnson and Johnson Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Johnson and Johnson Glaucoma Aqueous Shunt Device Sales by Product in 2024
11.3.6 Johnson and Johnson Glaucoma Aqueous Shunt Device Sales by Application in 2024
11.3.7 Johnson and Johnson Glaucoma Aqueous Shunt Device Sales by Geographic Area in 2024
11.3.8 Johnson and Johnson Glaucoma Aqueous Shunt Device SWOT Analysis
11.3.9 Johnson and Johnson Recent Developments
11.4 Advanced Ophthalmic Innovations (AOI)
11.4.1 Advanced Ophthalmic Innovations (AOI) Corporation Information
11.4.2 Advanced Ophthalmic Innovations (AOI) Business Overview
11.4.3 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.4.4 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device Sales by Product in 2024
11.4.6 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device Sales by Application in 2024
11.4.7 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device Sales by Geographic Area in 2024
11.4.8 Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device SWOT Analysis
11.4.9 Advanced Ophthalmic Innovations (AOI) Recent Developments
11.5 New World Medical
11.5.1 New World Medical Corporation Information
11.5.2 New World Medical Business Overview
11.5.3 New World Medical Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.5.4 New World Medical Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 New World Medical Glaucoma Aqueous Shunt Device Sales by Product in 2024
11.5.6 New World Medical Glaucoma Aqueous Shunt Device Sales by Application in 2024
11.5.7 New World Medical Glaucoma Aqueous Shunt Device Sales by Geographic Area in 2024
11.5.8 New World Medical Glaucoma Aqueous Shunt Device SWOT Analysis
11.5.9 New World Medical Recent Developments
11.6 Nova Eye Medical
11.6.1 Nova Eye Medical Corporation Information
11.6.2 Nova Eye Medical Business Overview
11.6.3 Nova Eye Medical Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.6.4 Nova Eye Medical Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Nova Eye Medical Recent Developments
11.7 Glaukos Corp
11.7.1 Glaukos Corp Corporation Information
11.7.2 Glaukos Corp Business Overview
11.7.3 Glaukos Corp Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.7.4 Glaukos Corp Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Glaukos Corp Recent Developments
11.8 Alcon
11.8.1 Alcon Corporation Information
11.8.2 Alcon Business Overview
11.8.3 Alcon Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.8.4 Alcon Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Alcon Recent Developments
11.9 iSTAR Medical
11.9.1 iSTAR Medical Corporation Information
11.9.2 iSTAR Medical Business Overview
11.9.3 iSTAR Medical Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.9.4 iSTAR Medical Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 iSTAR Medical Recent Developments
11.10 Henan Universe
11.10.1 Henan Universe Corporation Information
11.10.2 Henan Universe Business Overview
11.10.3 Henan Universe Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.10.4 Henan Universe Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Henan Universe Recent Developments
11.11 Ocular Therapeutix
11.11.1 Ocular Therapeutix Corporation Information
11.11.2 Ocular Therapeutix Business Overview
11.11.3 Ocular Therapeutix Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.11.4 Ocular Therapeutix Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Ocular Therapeutix Recent Developments
11.12 PolyActiva
11.12.1 PolyActiva Corporation Information
11.12.2 PolyActiva Business Overview
11.12.3 PolyActiva Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.12.4 PolyActiva Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 PolyActiva Recent Developments
11.13 Health Guard Biomed
11.13.1 Health Guard Biomed Corporation Information
11.13.2 Health Guard Biomed Business Overview
11.13.3 Health Guard Biomed Glaucoma Aqueous Shunt Device Product Models, Descriptions and Specifications
11.13.4 Health Guard Biomed Glaucoma Aqueous Shunt Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Health Guard Biomed Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Glaucoma Aqueous Shunt Device Industry Chain
12.2 Glaucoma Aqueous Shunt Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Glaucoma Aqueous Shunt Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Glaucoma Aqueous Shunt Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Glaucoma Aqueous Shunt Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Glaucoma Aqueous Shunt Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Glaukos Corp
Ocular Therapeutix
PolyActiva
Nova Eye Medical
Alcon
iSTAR Medical
Henan Universe
Health Guard Biomed
List of Tables
 Table 1. Global Glaucoma Aqueous Shunt Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Glaucoma Aqueous Shunt Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Glaucoma Aqueous Shunt Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Glaucoma Aqueous Shunt Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Glaucoma Aqueous Shunt Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Glaucoma Aqueous Shunt Device Sales by Region (2020-2025) & (K Units)
 Table 8. Global Glaucoma Aqueous Shunt Device Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Glaucoma Aqueous Shunt Device Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Glaucoma Aqueous Shunt Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Glaucoma Aqueous Shunt Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Glaucoma Aqueous Shunt Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Glaucoma Aqueous Shunt Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glaucoma Aqueous Shunt Device as of 2024)
 Table 16. Global Glaucoma Aqueous Shunt Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Glaucoma Aqueous Shunt Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Glaucoma Aqueous Shunt Device Manufacturing Base and Headquarters
 Table 19. Global Glaucoma Aqueous Shunt Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Glaucoma Aqueous Shunt Device Sales by Type (2020-2025) & (K Units)
 Table 23. Global Glaucoma Aqueous Shunt Device Sales by Type (2026-2031) & (K Units)
 Table 24. Global Glaucoma Aqueous Shunt Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Glaucoma Aqueous Shunt Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Glaucoma Aqueous Shunt Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Glaucoma Aqueous Shunt Device Sales by Application (2020-2025) & (K Units)
 Table 29. Global Glaucoma Aqueous Shunt Device Sales by Application (2026-2031) & (K Units)
 Table 30. Glaucoma Aqueous Shunt Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Glaucoma Aqueous Shunt Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Glaucoma Aqueous Shunt Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Glaucoma Aqueous Shunt Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Glaucoma Aqueous Shunt Device Growth Accelerators and Market Barriers
 Table 37. North America Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Glaucoma Aqueous Shunt Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Glaucoma Aqueous Shunt Device Growth Accelerators and Market Barriers
 Table 40. Europe Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Glaucoma Aqueous Shunt Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Glaucoma Aqueous Shunt Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Glaucoma Aqueous Shunt Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Glaucoma Aqueous Shunt Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Glaucoma Aqueous Shunt Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Glaucoma Aqueous Shunt Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. AbbVie Corporation Information
 Table 51. AbbVie Description and Major Businesses
 Table 52. AbbVie Product Models, Descriptions and Specifications
 Table 53. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. AbbVie Sales Value Proportion by Product in 2024
 Table 55. AbbVie Sales Value Proportion by Application in 2024
 Table 56. AbbVie Sales Value Proportion by Geographic Area in 2024
 Table 57. AbbVie Glaucoma Aqueous Shunt Device SWOT Analysis
 Table 58. AbbVie Recent Developments
 Table 59. Santen Pharmaceutical Corporation Information
 Table 60. Santen Pharmaceutical Description and Major Businesses
 Table 61. Santen Pharmaceutical Product Models, Descriptions and Specifications
 Table 62. Santen Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Santen Pharmaceutical Sales Value Proportion by Product in 2024
 Table 64. Santen Pharmaceutical Sales Value Proportion by Application in 2024
 Table 65. Santen Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 66. Santen Pharmaceutical Glaucoma Aqueous Shunt Device SWOT Analysis
 Table 67. Santen Pharmaceutical Recent Developments
 Table 68. Johnson and Johnson Corporation Information
 Table 69. Johnson and Johnson Description and Major Businesses
 Table 70. Johnson and Johnson Product Models, Descriptions and Specifications
 Table 71. Johnson and Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Johnson and Johnson Sales Value Proportion by Product in 2024
 Table 73. Johnson and Johnson Sales Value Proportion by Application in 2024
 Table 74. Johnson and Johnson Sales Value Proportion by Geographic Area in 2024
 Table 75. Johnson and Johnson Glaucoma Aqueous Shunt Device SWOT Analysis
 Table 76. Johnson and Johnson Recent Developments
 Table 77. Advanced Ophthalmic Innovations (AOI) Corporation Information
 Table 78. Advanced Ophthalmic Innovations (AOI) Description and Major Businesses
 Table 79. Advanced Ophthalmic Innovations (AOI) Product Models, Descriptions and Specifications
 Table 80. Advanced Ophthalmic Innovations (AOI) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Advanced Ophthalmic Innovations (AOI) Sales Value Proportion by Product in 2024
 Table 82. Advanced Ophthalmic Innovations (AOI) Sales Value Proportion by Application in 2024
 Table 83. Advanced Ophthalmic Innovations (AOI) Sales Value Proportion by Geographic Area in 2024
 Table 84. Advanced Ophthalmic Innovations (AOI) Glaucoma Aqueous Shunt Device SWOT Analysis
 Table 85. Advanced Ophthalmic Innovations (AOI) Recent Developments
 Table 86. New World Medical Corporation Information
 Table 87. New World Medical Description and Major Businesses
 Table 88. New World Medical Product Models, Descriptions and Specifications
 Table 89. New World Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. New World Medical Sales Value Proportion by Product in 2024
 Table 91. New World Medical Sales Value Proportion by Application in 2024
 Table 92. New World Medical Sales Value Proportion by Geographic Area in 2024
 Table 93. New World Medical Glaucoma Aqueous Shunt Device SWOT Analysis
 Table 94. New World Medical Recent Developments
 Table 95. Nova Eye Medical Corporation Information
 Table 96. Nova Eye Medical Description and Major Businesses
 Table 97. Nova Eye Medical Product Models, Descriptions and Specifications
 Table 98. Nova Eye Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Nova Eye Medical Recent Developments
 Table 100. Glaukos Corp Corporation Information
 Table 101. Glaukos Corp Description and Major Businesses
 Table 102. Glaukos Corp Product Models, Descriptions and Specifications
 Table 103. Glaukos Corp Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Glaukos Corp Recent Developments
 Table 105. Alcon Corporation Information
 Table 106. Alcon Description and Major Businesses
 Table 107. Alcon Product Models, Descriptions and Specifications
 Table 108. Alcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Alcon Recent Developments
 Table 110. iSTAR Medical Corporation Information
 Table 111. iSTAR Medical Description and Major Businesses
 Table 112. iSTAR Medical Product Models, Descriptions and Specifications
 Table 113. iSTAR Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. iSTAR Medical Recent Developments
 Table 115. Henan Universe Corporation Information
 Table 116. Henan Universe Description and Major Businesses
 Table 117. Henan Universe Product Models, Descriptions and Specifications
 Table 118. Henan Universe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Henan Universe Recent Developments
 Table 120. Ocular Therapeutix Corporation Information
 Table 121. Ocular Therapeutix Description and Major Businesses
 Table 122. Ocular Therapeutix Product Models, Descriptions and Specifications
 Table 123. Ocular Therapeutix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Ocular Therapeutix Recent Developments
 Table 125. PolyActiva Corporation Information
 Table 126. PolyActiva Description and Major Businesses
 Table 127. PolyActiva Product Models, Descriptions and Specifications
 Table 128. PolyActiva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. PolyActiva Recent Developments
 Table 130. Health Guard Biomed Corporation Information
 Table 131. Health Guard Biomed Description and Major Businesses
 Table 132. Health Guard Biomed Product Models, Descriptions and Specifications
 Table 133. Health Guard Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Health Guard Biomed Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. Glaucoma Aqueous Shunt Device Product Picture
 Figure 2. Global Glaucoma Aqueous Shunt Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Trabecular Meshwork-Schlemm Canal Drainage Product Picture
 Figure 4. Subconjunctival Drainage Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Glaucoma Aqueous Shunt Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Ophthalmology Clinics
 Figure 9. Others
 Figure 10. Glaucoma Aqueous Shunt Device Report Years Considered
 Figure 11. Global Glaucoma Aqueous Shunt Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Glaucoma Aqueous Shunt Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Glaucoma Aqueous Shunt Device Revenue Market Share by Region (2020-2031)
 Figure 15. Global Glaucoma Aqueous Shunt Device Sales (2020-2031) & (K Units)
 Figure 16. Global Glaucoma Aqueous Shunt Device Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Glaucoma Aqueous Shunt Device Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Glaucoma Aqueous Shunt Device Sales Volume Market Share in 2024
 Figure 19. Global Glaucoma Aqueous Shunt Device Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Trabecular Meshwork-Schlemm Canal Drainage Revenue Market Share by Manufacturer in 2024
 Figure 22. Subconjunctival Drainage Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Glaucoma Aqueous Shunt Device Sales Market Share by Type (2020-2031)
 Figure 25. Global Glaucoma Aqueous Shunt Device Revenue Market Share by Type (2020-2031)
 Figure 26. Global Glaucoma Aqueous Shunt Device Sales Market Share by Application (2020-2031)
 Figure 27. Global Glaucoma Aqueous Shunt Device Revenue Market Share by Application (2020-2031)
 Figure 28. North America Glaucoma Aqueous Shunt Device Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Glaucoma Aqueous Shunt Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) in 2024
 Figure 31. North America Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Glaucoma Aqueous Shunt Device Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Glaucoma Aqueous Shunt Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 46. France Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Glaucoma Aqueous Shunt Device Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Glaucoma Aqueous Shunt Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 61. India Glaucoma Aqueous Shunt Device Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Glaucoma Aqueous Shunt Device Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Glaucoma Aqueous Shunt Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Glaucoma Aqueous Shunt Device Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Glaucoma Aqueous Shunt Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Glaucoma Aqueous Shunt Device Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Glaucoma Aqueous Shunt Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Glaucoma Aqueous Shunt Device Revenue (2020-2025) & (US$ Million)
 Figure 82. Glaucoma Aqueous Shunt Device Industry Chain Mapping
 Figure 83. Regional Glaucoma Aqueous Shunt Device Manufacturing Base Distribution (%)
 Figure 84. Global Glaucoma Aqueous Shunt Device Production Market Share by Region (2020-2031)
 Figure 85. Glaucoma Aqueous Shunt Device Production Process
 Figure 86. Regional Glaucoma Aqueous Shunt Device Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13L12609
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32B20021
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38C19846
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H20253
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions